- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Motolimod (VTX-2337) analog and a toll-like receptor 8 (TLR8)-selective agonist with stronger activity than resiquimod (R848) and CL075 (3M002).
TL8-506 is a motolimod (VTX-2337) analog and a benzoazepine class toll-like receptor 8 (TLR8)-selective agonist. TL8-506 is commonly employed in the concentration range from 0.1 μg/mL to 1 μg/mL for stimulating cell surface TLR8 in cultures and is reported to be a stronger TLR8 ligand than the imidazoquinoline (IMDQ) derivatives (IQDs) resiquimod (R848) and CL075 (3M002).
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear (Warmed) |
| storage temp. | -10 to -25°C |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 2814.26
-
询价
-
询价
-
询价
-
询价
-
¥ 8520.40
-
¥ 3275.78
-
询价
-
¥ 3812.28
-
¥ 15214.65
-
询价
-
¥ 3335.66
-
¥ 2882.02
-
询价
-
¥ 5061.38
-
¥ 2277.64
-
¥ 2406.69
-
¥ 954.17
-
¥ 4476.05
微信小程序
7X24小时在线咨询